女æ§èªèº«ã®ãâå±éºãããå¯åå¿âã®å®æ ãã¨ããè¨äºã«ã¤ãã¦
- 死亡例も…子宮頚がんワクチン“危険すぎる副反応”の実態 女æ§èªèº« 3æ13æ¥(æ°´)7æ7åé ä¿¡
ã¨ããè¨äºãYahoo!ãã¥ã¼ã¹ã«ã¢ããããã¦ãã¾ããã¯ã¯ãã³ã«å対ã®ç«å ´ãã¨ãå»å¸«ã®è©±ãèãã¦ãããã®ã§ãã以ä¸æç²ã
ç¾å¨ãæ¥æ¬ã§æ¿èªããã¦ããåå®®é ¸ããã¯ã¯ãã³ã¯ããã¬ã¼ãã·ã«ãã¨ããµã¼ããªãã¯ã¹ãã®ãµãã¤ãã¢ã¡ãªã«ã®ã¯ã¯ãã³æ害äºè±¡å ±åå¶åº¦ãVAERSãã«ããã¨ããã¬ã¼ãã·ã«ãããµã¼ããªãã¯ã¹ãã®ä¸¡ã¯ã¯ãã³ã«ããå¯åå¿è¢«å®³è æ°ã¯å ¨ä¸çã§2ä¸8å661人ãæ»äº¡è æ°ã¯130人ã«ã®ã¼ã£ã¦ããã
ãããããããã¯å ±åããã件æ°ã ããå®éã«ã¯ãã®10å以ä¸ã®è¢«å®³è ãããã¨äºæ³ããã¦ãã¾ããè³æ©è½é害ã«ããæèä½ä¸ã§éç¥è¡¨ã®ãªã¼ã«Aã ã£ãå°å¥³ã®æ績ãã¬ã¿è½ã¡ããããæçµã®ãããªåºè¡ãç´è ¸ããã®åºè¡ãããªãã«ã¯çºç±ãå ¨èº«å¦æ æãªã©ã®çç¶ãåºã ããæ¥æ¬ã§é£ç ã«æå®ããã¦ããSLE(å ¨èº«æ§ã¨ãªãããã¼ãã¹)ã«ããããå¯ãããã«ãªã£ãçä¾ãããã¾ããï¼ä½è¤é¢é·ï¼
ä¸è¨ã«ã¯ã大ããªäºå®èª¤èªãããã¾ããVAERSã¯ç±³å½æ害äºè±¡å ±åå¶åº¦ã§ãã¯ã¯ãã³ã¨ã®å æé¢ä¿ãåãããæ¥ç¨®å¾ã«å¥åº·ä¸ã®åé¡ãèµ·ããå ´åã«ãã¤ã§ããå»å¸«ã»è¢«æ¥ç¨®è
ãªã©ãå ±åããã¨ããå¶åº¦ã§ããã¡æ©ãã¯ã¯ãã³ã¨å æé¢ä¿ã®ããå¯åå¿ãå¯ç¥ããããã®ãã®ã§ããVAERSãã¼ã¿ãã¼ã¹ã«é¢ãã¦ã¯ä»¥åæ¬ããã°ã§åãä¸ãããã¨ãããã¾ãã
- 子宮頸がんワクチン副作用者数一覧?有害事象と副反応 ããããã¡ã¢
VAERSデータベースのトップページã«ãã注ææ¸ããå訳ãããã®ãåæ²ãã¦ããã¾ãã
VAERSçä¾å ±åæ å ±ã解éããããã«
VAERSã®ãã¼ã¿ãè©ä¾¡ããéã«éè¦ãªãã¨ã¯ãå ±åãããäºè±¡ã¯ã©ããå æé¢ä¿ã証æããããã®ã§ã¯ãªããã¨ã«çæãããã¨ã§ããã¯ã¯ãã³ãæ害äºè±¡ã«é¢ä¸ãã¦ããå¯è½æ§ã®ãããããããå ±åï¼å¯åå¿ã®å¯è½æ§ï¼ãVAERSã«æåºããã¾ããVAERSã¯ã¯ã¯ãã³æ¥ç¨®å¾ã®ããããæ害äºè±¡ã«é¢ãããã¼ã¿ãåéãã¦ããããã®äºè±¡ãå¶ç¶ã¯ã¯ãã³æ¥ç¨®ã¨åææã«èµ·ããã®ããçã«ã¯ã¯ãã³ã«ãããã®ãã¯åãã¾ãããVAERSã«å¯ããããæ害äºè±¡ã®å ±åã¯ãã¯ã¯ãã³ããã®æ害äºè±¡ã®åå ã§ãããã¨ã®è¨¼æ æ¸é¡ã§ã¯ããã¾ããã
ï¼åæï¼
When evaluating data from VAERS, it is important to note that for any reported event, no cause-and-effect relationship has been established. Reports of all possible associations between vaccines and adverse events (possible side effects) are filed in VAERS. Therefore, VAERS collects data on any adverse event following vaccination, be it coincidental or truly caused by a vaccine. The report of an adverse event to VAERS is not documentation that a vaccine caused the event.
ã¾ããå¥ã®ã¨ã³ããªãããCDCï¼ç±³å½ç¾ç äºé²ç®¡çã»ã³ã¿ã¼ï¼ã®ã¯ã¯ãã³å®å ¨æ§Q&Aã®ãVAERSã«é¢ããé¨åãæç²ãã¾ãã
- CDC(米国疾病予防管理センター)の子宮頸がんワクチンに関するFAQ ããããã¡ã¢
Vaccine Adverse Event Reporting Systemï¼ã¯ã¯ãã³æ害äºè±¡å ±åã·ã¹ãã ãVAERSï¼ã¯ãã¯ã¯ãã³æ¥ç¨®å¾ã®å¥åº·ä¸ã®åé¡ï¼ãæ害äºè±¡ãã¨å¼ã°ãã¾ãï¼ã®å ±åãåçãã¾ããVAERSå ±åã¯ã¤ã³ã¿ã¼ããããéµéãFAXã«ããåãä»ãã¦ãã¾ãã VAERSå ±åãè¡ãã®ã¯ãå»å¸«ãä¿è·è ãããã¯å®¶æãã¯ã¯ãã³è¢«æ¥ç¨®è ãåã¯è£½é æ¥è ã§ããå ±åã¯ãã¯ã¯ãã³æ¥ç¨®å¾ããã¤ã§ãæåºã§ãã¾ããã¤ã¾ããã¯ã¯ãã³æ¥ç¨®ã®æ°ã¶æãæ°å¹´å¾ã«èµ·ãã£ãå¥åº·ä¸ã®åé¡ãå ±åã§ããã®ã§ããå ±åã¯ãã¹ã¦ãFDAåã³CDCã®è¨ç·´ãåããã¹ã¿ããã«ããã¬ãã¥ã¼ããã¾ããVAERSã«ãããã¯ã¯ãã³ããã®æ害äºè±¡ã®åå ã§ãããããããªãï¼å¯åå¿ã®å¯è½æ§ï¼ãã¨ã示ãå ±åã®ãã¿ã¼ã³ãè¦ã¤ãããã¨ãã§ãã¾ãããã ããã¯ã¯ãã³ãããæ害äºè±¡ã®åå ã ã¨æå®ããã®ã«ã¯å©ç¨ã§ãã¾ããã
åæã¯ãã¡ã
Frequently Asked Questions about HPV Vaccine Safety
以ä¸ã®ããã«ããã®è¨äºã¯äºå®èª¤èªã«åºã¥ãã¦ãã¾ãã
ããã«ç¶ãããã®10åã®æ°ãâ¦ãäºã ã«ã¤ãã¦ã¯ãªãã®è¨¼æ ããªã話ã§ãã誰ãåãã¾ã¨ãã¦ãªãã誰ã«ãå ±åããã¦ããªãæ°ãã©ããã£ã¦ç¥ã£ãã®ã§ããããï¼ãã®å çã¯ãVAERS以ä¸ã®æ å ±ç¶²ã§ãæ害äºè±¡æ å ±ãã¾ã¨ãããã§ããããï¼
è¨äºå¾åã«ã¯ãåçå´åçã¯ãã®ããµã¼ããªãã¯ã¹ãã®å½å ã§ã®å¯åå¿ã®é篤çç¶ãå ¬éãã¦ããã60ãã¼ã¸ä»¥ä¸ã«åã¶å ±åæ¸ã«ã¯ã09å¹´12æã«å½å ã§ã®è²©å£²ãéå§ããã¦ããâ12å¹´ã®8ææ«ã¾ã§ãã®ã¹1å628件ã®å¯åå¿å ±åã綴ããã¦ããããã¨ã®è¨è¿°ãè¦ããã¾ããããã®å è³æã¯ããã ã¨æããã¾ãã
ãã®ã¹1628件ãã¯ãã製é 販売æ¥è ããã®å ±åã672ä¾ã¨ãå»çæ©é¢ããã®å ±åã956ä¾ã®åè¨æ°ãªã®ã§ããããã®è¡¨ã®ä¸é¨ã«ã¯ä»¥ä¸ã®æ§ãªæ³¨ææ¸ããããã¾ãã
⻠製é 販売æ¥è ããã®å¯åå¿å ±åã¯ãè¬äºæ³ç¬¬77 æ¡ã®4 ã®2 ã«åºã¥ããé篤ãã¨å¤æãããçä¾ã«ã¤ãã¦å ±åããããã®ã§ããããªãã製é 販売æ¥è ããã®å ±åã«ã¯ãå»çæ©é¢ããå ±åãããçä¾ã¨éè¤ãã¦ããçä¾ãå«ã¾ãã¦ããå¯è½æ§ããããã¾ãããã®å¾ã®èª¿æ»çã«ãã£ã¦ãå ±å対象ã§ãªããã¨ã確èªãããå ±åãåãä¸ããããçä¾ãå«ã¾ããå¯è½æ§ãããã
ã¾ãã次ã®ãã¼ã¸ã®å»çæ©é¢ããã®å ±åã®ã¾ã¨ãã®ä¸ã«ã¯ä»¥ä¸ã®ãããªæ³¨ææ¸ããããã¾ãã
ä»åã®æ¥ç¨®äºæ¥ã§ã¯ãæ¥ç¨®ã¨ã®å æé¢ä¿ã®æç¡ã«é¢ãããããæ¥ç¨®å¾ã®æ»äº¡ãè¨åºçç¶ã®é篤ãªãã®ãå¾éºçãæ®ãå¯è½æ§ã®ãããã®ãã«è©²å½ããã¨å¤æããããã®ãå ±å対象ã¨ãã¦ããã
ã¤ã¾ããå»çæ©é¢ã¨è£½é 販売æ¥è ãéè¤ãã¦å ±åãã¦ããæ°ã足ãã¦ããä¸ãã¯ã¯ãã³æ¥ç¨®ã¨å æé¢ä¿ããªãã¨èãããããã®ãå«ã¾ããã¦ãã®ãã1628ãä¾ããªã®ã§ããã¡ãªã¿ã«åçå´åçã®è¡¨ã§ã¯ãã®åè¨æ°ã¯è¨è¼ããã¦ãã¾ãããéè¤ããããããåè¨ãã¦ãæå³ããªãæ°åã ããã§ããä¸è¨ã®è³æãããå ±åå ¨ä½ã®è¡¨ã¨å»çæ©é¢ã«ãã£ã¦ã¯ã¯ãã³ã¨ã®å æé¢ä¿ããã¨è©ä¾¡ãããå ±åæ°ã®è¡¨ãå¼ç¨ãã¦ããã¾ãããã ãããã®å ±åã¯å»çæ©é¢ããã®ãã®ã«éããã¦ããããVAERSã»ã©ç¶²ç¾ ãã¦ããªãã¨æããã¾ãã
æ®å¿µãªãããå¯åå¿ã®ãªãã¯ã¯ãã³ã¯ããã¾ãããæ¥ç¨®ãããã©ããã®å¤æã«ãå¯åå¿ã®èµ·ããé »åº¦ã¯éè¦ãªæ
å ±ã¨ãªãã¾ãããã®ãããªèª¤ã¾ã£ãæ
å ±ãããã¨ã女æ§é±åèªã¨è¨ãã©ã大å¢ã®äººãèªãéèªã«æ²è¼ããç¡è²¬ä»»ãã«åããã°ããã§ãã
åå®®é ¸ããã¯ã¯ãã³ã®æ¥ç¨®ã®å¯å¦ã®å¤æã«ã¤ãã¦ããã¡ãã®ã¾ã¨ããåèã«ãªãã¨æãã¾ãã
ã¾ããåå®®é ¸ãããã®ãã®ã«ã¤ãã¦ãããæ
å ±ãµã¼ãã¹ã®ãã¼ã¸ã§ããå¹´éã©ã®ãããã®äººãç½¹æ£ããã®ããæ²»çæ³ãªã©ããããããªæ
å ±ãæ²è¼ããã¦ãã¾ããç§å¦çäºå®ãçµ±è¨ã«åºã¥ãã¦ã¾ã¨ãããã¦ãããä¿¡é ¼åºæ¥ãæ
å ±ã§ãã